GATA2 deficiency is a rare primary immunodeficiency (PID), first described in 2011[1–3] that has become gradually more recognized due to improved molecular diagnostics and increased clinical awareness. The gene discussed is GATA2; the disease is hyperinsulinemic hypoglycemia, familial, 4.